Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
Is a |
Product containing benzocaine (medicinal product) |
false |
Inferred relationship |
Some |
|
|
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
Is a |
Product containing trimethobenzamide (medicinal product) |
false |
Inferred relationship |
Some |
|
|
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Ethanolamine |
false |
Inferred relationship |
Some |
|
|
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
antiallergique |
false |
Inferred relationship |
Some |
|
|
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Trimethobenzamide (substance) |
false |
Inferred relationship |
Some |
|
|
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
agent procinétique |
false |
Inferred relationship |
Some |
|
|
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Benzocaine (substance) |
false |
Inferred relationship |
Some |
|
|
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
Is a |
Product containing benzocaine and trimethobenzamide hydrochloride |
false |
Inferred relationship |
Some |
|
|
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Trimethobenzamide hydrochloride |
false |
Inferred relationship |
Some |
|
|
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Histamine receptor antagonist |
false |
Inferred relationship |
Some |
|
|
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Cardiovascular agent (substance) |
false |
Inferred relationship |
Some |
|
|
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
Has manufactured dose form |
Rectal dose form (dose form) |
false |
Inferred relationship |
Some |
|
|
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
Is a |
Benzocaine-containing product in rectal dose form |
false |
Inferred relationship |
Some |
|
|
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
Is a |
Trimethobenzamide-containing product in rectal dose form |
false |
Inferred relationship |
Some |
|
|
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
Has manufactured dose form |
Rectal suppository |
true |
Inferred relationship |
Some |
|
|
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
Is a |
TEMPORARY parent for CDs that are not updated |
false |
Inferred relationship |
Some |
|
|
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
This attribute specifies the denominator unit for the presentation strength of a product. |
Suppository (unit of presentation) |
true |
Inferred relationship |
Some |
1 |
|
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
Has presentation strength denominator value |
un |
false |
Inferred relationship |
Some |
2 |
|
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
Has unit of presentation |
Suppository (unit of presentation) |
true |
Inferred relationship |
Some |
|
|
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
Count of base of active ingredient |
deux |
false |
Inferred relationship |
Some |
|
|
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
Is a |
Benzocaine and trimethobenzamide only product in rectal dose form |
true |
Inferred relationship |
Some |
|
|
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
Has presentation strength denominator value |
un |
false |
Inferred relationship |
Some |
1 |
|
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
This attribute specifies the denominator unit for the presentation strength of a product. |
Suppository (unit of presentation) |
true |
Inferred relationship |
Some |
2 |
|
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
This attribute specifies the numerator unit for the presentation strength of a product. |
mg |
true |
Inferred relationship |
Some |
1 |
|
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Benzocaine (substance) |
true |
Inferred relationship |
Some |
2 |
|
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
Benzocaine (substance) |
true |
Inferred relationship |
Some |
2 |
|
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
Has presentation strength numerator value |
20 |
false |
Inferred relationship |
Some |
2 |
|
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
This attribute specifies the numerator unit for the presentation strength of a product. |
mcg |
true |
Inferred relationship |
Some |
2 |
|
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Trimethobenzamide hydrochloride |
true |
Inferred relationship |
Some |
1 |
|
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
Has presentation strength numerator value |
200 |
false |
Inferred relationship |
Some |
1 |
|
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
Trimethobenzamide hydrochloride |
true |
Inferred relationship |
Some |
1 |
|
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
Plays role |
Antiemetic therapeutic role (role) |
false |
Inferred relationship |
Some |
|
|